ArticleNMR in biomedicine2010
Semi-parametric time-domain quantification of HR-MAS data from prostate tissue.
Article in NMR in biomedicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Article
- Deciphering the Role ofJournal of biomedical science and engineering · 2022Article
- Chemical-Shift-Encoded Magnetic Resonance Imaging and Spectroscopy to Reveal Immediate and Long-Term Multi-Organs Composition Changes of a 14-Days Periodic Fasting Intervention: A Technological and Case Report.Frontiers in nutrition · 2019Article
- Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor.Translational oncology · 2017Article
- Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma.Scientific reports · 2017Article
- Creatine, Glutamine plus Glutamate, and Macromolecules Are Decreased in the Central White Matter of Premature Neonates around Term.PloS one · 2016Article
- A combined chemometric and quantitative NMR analysis of HIV/AIDS serum discloses metabolic alterations associated with disease status.Molecular bioSystems · 2014Article
- Characterization of metabolites in infiltrating gliomas using ex vivo ¹H high-resolution magic angle spinning spectroscopy.NMR in biomedicine · 2014Article
- Evaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate.NMR in biomedicine · 2014Article
- Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.Current Metabolomics · 2014Article
- The role of metabolic imaging in radiation therapy of prostate cancer.NMR in biomedicine · 2014Review
- High-resolution magic angle spinning 1H MRS in prostate cancer.NMR in biomedicine · 2014Review
- Identifying malignant transformations in recurrent low grade gliomas using high resolution magic angle spinning spectroscopy.Artificial intelligence in medicine · 2012Article
- Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas.Science translational medicine · 2012Article
- A decade in prostate cancer: from NMR to metabolomics.Nature reviews. Urology · 2011Review
- Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma.Journal of magnetic resonance imaging : JMRI · 2011Article
- Response of Degarelix treatment in human prostate cancer monitored by HR-MASMetabolomics : Official journal of the Metabolomic SocietyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
High Resolution--Magic Angle Spinning (HR-MAS) spectroscopy provides rich biochemical profiles that require accurate quantification to permit biomarker identification and to understand the underlying pathological mechanisms. Meanwhile, quantification of HR-MAS data from prostate tissue samples is challenging due to significant overlap between the resonant peaks, the presence of short T₂* metabolites such as citrate or polyamines (T₂ from 25 to 100 msec) and macromolecules, and variations in chemical shifts and T₂*s within a metabolite's spin systems. Since existing methods do not address these challenges completely, a new quantification method was developed and optimized for HR-MAS data acquired with an ultra short T(E) and over 30,000 data points. The proposed method, named HR-QUEST (High Resolution--QUEST), iteratively employs the QUEST time-domain semi-parametric strategy with a new model function that incorporates prior knowledge from whole and subdivided metabolite signals. With these features, HR-QUEST is able to independently fit the chemical shifts and T₂*s of a metabolite's spin systems, a necessity for HR-MAS data. By using the iterative fitting approach, it is able to account for significant contributions from macromolecules and to handle shorter T₂ metabolites, such as citrate and polyamines. After subdividing the necessary metabolite basis signals, the root mean square (RMS) of the residual was reduced by 52% for measured HR-MAS data from prostate tissue. Monte Carlo studies on simulated spectra with varied macromolecular contributions showed that the iterative fitting approach (6 iterations) coupled with inclusion of long T₂ macromolecule components in the basis set improve the quality of the fit, as assessed by the reduction of the RMS of the residual and of the RMS error of the metabolite signal estimate, by 27% and 71% respectively. With this optimized configuration, HR-QUEST was applied to measured HR-MAS prostate data and reliably quantified 16 metabolites and reference signals with estimated Cramér Rao Bounds ≤5%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.